AVITA Medical, Inc. (RCEL) Misses Q1 EPS by 41c

AVITA Medical, Inc. (NASDAQ: RCEL) reported Q1 EPS of ($0.73), $0.41 worse than the analyst estimate of ($0.32). Revenue for the quarter came in at $11.1 million versus the consensus estimate of $12.02 million.

For earnings history and earnings-related data on AVITA Medical, Inc. (RCEL) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Rein Therapeutics Inc. (RNTX) Tops Q2 EPS by 39c
• Outlook Therapeutics (OTLK) Misses Q3 EPS by 9c